Topotecan's Potential in Cancer Treatment
Author Information
Author(s): Nagourney R A, Sommers B L, Harper S M, Radecki S, Evans S S
Primary Institution: Rational Therapeutics, Inc.
Hypothesis
Can topotecan be effective in treating various types of cancer beyond its current approvals?
Conclusion
Topotecan shows significant activity in non-small-cell lung cancer and breast cancer, suggesting it may be a viable treatment option for these cancers.
Supporting Evidence
- Topotecan has shown activity in non-small-cell lung cancer and breast cancer.
- Ex vivo analyses can provide insights into drug activity profiles.
- Topotecan's mechanism suggests potential for synergy with other drugs.
Takeaway
Topotecan is a medicine that can help treat certain types of cancer, especially lung and breast cancer, by making cancer cells die.
Methodology
The study used ex vivo assays on human tumor biopsy specimens to evaluate the activity of topotecan and its combinations with other drugs.
Potential Biases
Potential bias in patient selection and the influence of prior treatments on drug response.
Limitations
The study primarily focused on specific cancer types and may not generalize to all cancers.
Participant Demographics
Patients with previously untreated non-small-cell lung cancer, breast, colorectal, and prostate cancers.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website